Cresco Labs Inc. (CL.CN)
CAD 1.23
(-1.6%)
CAD 1.23
(-1.6%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.35 Billion USD | -14.22% |
| 2022 | 1.58 Billion USD | -11.05% |
| 2021 | 1.78 Billion USD | 33.56% |
| 2020 | 1.33 Billion USD | 116.22% |
| 2019 | 616.55 Million USD | 93.82% |
| 2018 | 318.11 Million USD | 17304128.52% |
| 2017 | 1838.34 USD | -97.57% |
| 2016 | 75.74 Thousand USD | -32.16% |
| 2015 | 111.65 Thousand USD | -11.36% |
| 2014 | 125.96 Thousand USD | -32.85% |
| 2013 | 187.57 Thousand USD | -9.51% |
| 2012 | 207.27 Thousand USD | -10.7% |
| 2011 | 232.1 Thousand USD | -43.72% |
| 2010 | 412.42 Thousand USD | -83.51% |
| 2009 | 2.5 Million USD | -41.7% |
| 2008 | 4.29 Million USD | -39.61% |
| 2007 | 7.1 Million USD | 42.29% |
| 2006 | 4.99 Million USD | 0.36% |
| 2005 | 4.97 Million USD | 78.23% |
| 2004 | 2.79 Million USD | 209.17% |
| 2003 | 902.79 Thousand USD | 124.61% |
| 2002 | 401.93 Thousand USD | 19.47% |
| 2001 | 336.43 Thousand USD | -7.29% |
| 2000 | 362.9 Thousand USD | -24.2% |
| 1999 | 478.73 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 1.36 Billion USD | 0.12% |
| 2024 Q2 | 1.35 Billion USD | -0.15% |
| 2023 Q1 | 1.55 Billion USD | -2.09% |
| 2023 Q4 | 1.35 Billion USD | -2.91% |
| 2023 Q3 | 1.39 Billion USD | -7.42% |
| 2023 Q2 | 1.51 Billion USD | -2.54% |
| 2023 FY | 1.35 Billion USD | -14.22% |
| 2022 Q2 | 1.7 Billion USD | -4.7% |
| 2022 Q3 | 1.75 Billion USD | 3.25% |
| 2022 Q4 | 1.58 Billion USD | -9.83% |
| 2022 FY | 1.58 Billion USD | -11.05% |
| 2022 Q1 | 1.78 Billion USD | 0.25% |
| 2021 Q1 | 1.4 Billion USD | 5.55% |
| 2021 Q2 | 1.59 Billion USD | 13.38% |
| 2021 FY | 1.78 Billion USD | 33.56% |
| 2021 Q4 | 1.78 Billion USD | 13.41% |
| 2021 Q3 | 1.56 Billion USD | -1.6% |
| 2020 Q2 | 1.2 Billion USD | 4.5% |
| 2020 Q3 | 1.2 Billion USD | -0.2% |
| 2020 FY | 1.33 Billion USD | 116.22% |
| 2020 Q4 | 1.33 Billion USD | 10.48% |
| 2020 Q1 | 1.15 Billion USD | 87.66% |
| 2019 Q3 | 416.52 Million USD | 17.32% |
| 2019 Q1 | 364.04 Million USD | 14.44% |
| 2019 Q2 | 355.03 Million USD | -2.48% |
| 2019 Q4 | 616.55 Million USD | 48.02% |
| 2019 FY | 616.55 Million USD | 93.82% |
| 2018 FY | 318.11 Million USD | 17304128.52% |
| 2018 Q3 | 80.64 Thousand USD | 12261.28% |
| 2018 Q1 | 2345.73 USD | 27.6% |
| 2018 Q2 | 652.38 USD | -72.19% |
| 2018 Q4 | 318.11 Million USD | 394373.1% |
| 2017 Q2 | 466.96 USD | 93.68% |
| 2017 Q4 | 1838.34 USD | 305.23% |
| 2017 FY | 1838.34 USD | -97.57% |
| 2017 Q1 | 241.10 USD | -99.68% |
| 2017 Q3 | 453.66 USD | -2.85% |
| 2016 Q1 | 124.36 Thousand USD | 11.39% |
| 2016 FY | 75.74 Thousand USD | -32.16% |
| 2016 Q3 | 117.52 Thousand USD | -2.37% |
| 2016 Q4 | 75.74 Thousand USD | -35.55% |
| 2016 Q2 | 120.37 Thousand USD | -3.21% |
| 2015 Q2 | 124.16 Thousand USD | -7.42% |
| 2015 FY | 111.65 Thousand USD | -11.36% |
| 2015 Q1 | 134.12 Thousand USD | 6.48% |
| 2015 Q4 | 111.65 Thousand USD | -9.99% |
| 2015 Q3 | 124.04 Thousand USD | -0.09% |
| 2014 FY | 125.96 Thousand USD | -32.85% |
| 2014 Q1 | 188.32 Thousand USD | 0.4% |
| 2014 Q2 | 183.28 Thousand USD | -2.68% |
| 2014 Q3 | 179.38 Thousand USD | -2.13% |
| 2014 Q4 | 125.96 Thousand USD | -29.78% |
| 2013 Q4 | 187.57 Thousand USD | -6.72% |
| 2013 Q3 | 201.07 Thousand USD | -8.5% |
| 2013 FY | 187.57 Thousand USD | -9.51% |
| 2013 Q1 | 202.37 Thousand USD | -2.36% |
| 2013 Q2 | 219.74 Thousand USD | 8.58% |
| 2012 Q3 | 266.16 Thousand USD | 3.79% |
| 2012 Q4 | 207.27 Thousand USD | -22.12% |
| 2012 FY | 207.27 Thousand USD | -10.7% |
| 2012 Q1 | 248.78 Thousand USD | 7.18% |
| 2012 Q2 | 256.44 Thousand USD | 3.08% |
| 2011 Q4 | 232.1 Thousand USD | -28.17% |
| 2011 FY | 232.1 Thousand USD | -43.72% |
| 2011 Q3 | 323.13 Thousand USD | -6.18% |
| 2011 Q2 | 344.42 Thousand USD | -22.15% |
| 2011 Q1 | 442.39 Thousand USD | 7.27% |
| 2010 Q4 | 412.42 Thousand USD | -83.48% |
| 2010 Q1 | 2.56 Million USD | 2.47% |
| 2010 Q2 | 2.46 Million USD | -3.76% |
| 2010 Q3 | 2.49 Million USD | 1.22% |
| 2010 FY | 412.42 Thousand USD | -83.51% |
| 2009 Q4 | 2.5 Million USD | -49.92% |
| 2009 Q1 | 4.46 Million USD | 4.12% |
| 2009 Q2 | 4.91 Million USD | 10.06% |
| 2009 Q3 | 4.99 Million USD | 1.58% |
| 2009 FY | 2.5 Million USD | -41.7% |
| 2008 Q2 | 6.91 Million USD | -0.78% |
| 2008 Q3 | 4.66 Million USD | -32.59% |
| 2008 Q1 | 6.97 Million USD | -1.89% |
| 2008 FY | 4.29 Million USD | -39.61% |
| 2008 Q4 | 4.29 Million USD | -7.97% |
| 2007 FY | 7.1 Million USD | 42.29% |
| 2007 Q4 | 7.1 Million USD | -4.1% |
| 2007 Q3 | 7.4 Million USD | 10.83% |
| 2007 Q2 | 6.68 Million USD | 24.6% |
| 2007 Q1 | 5.36 Million USD | 7.45% |
| 2006 Q3 | 5.72 Million USD | 0.35% |
| 2006 Q2 | 5.7 Million USD | -0.23% |
| 2006 Q1 | 5.71 Million USD | 14.93% |
| 2006 FY | 4.99 Million USD | 0.36% |
| 2006 Q4 | 4.99 Million USD | -12.78% |
| 2005 Q3 | 4.79 Million USD | 49.24% |
| 2005 Q1 | 2.65 Million USD | -4.96% |
| 2005 Q2 | 3.21 Million USD | 21.22% |
| 2005 Q4 | 4.97 Million USD | 3.66% |
| 2005 FY | 4.97 Million USD | 78.23% |
| 2004 Q1 | 888.54 Thousand USD | -1.58% |
| 2004 Q2 | 1.14 Million USD | 29.06% |
| 2004 Q3 | 1.48 Million USD | 29.89% |
| 2004 FY | 2.79 Million USD | 209.17% |
| 2004 Q4 | 2.79 Million USD | 87.39% |
| 2003 FY | 902.79 Thousand USD | 124.61% |
| 2003 Q1 | 427.76 Thousand USD | 6.43% |
| 2003 Q4 | 902.79 Thousand USD | 76.12% |
| 2003 Q3 | 512.59 Thousand USD | 17.45% |
| 2003 Q2 | 436.44 Thousand USD | 2.03% |
| 2002 Q2 | 390.6 Thousand USD | 1.53% |
| 2002 Q3 | 407.01 Thousand USD | 4.2% |
| 2002 Q4 | 401.93 Thousand USD | -1.25% |
| 2002 FY | 401.93 Thousand USD | 19.47% |
| 2002 Q1 | 384.7 Thousand USD | 0.0% |
| 2001 FY | 336.43 Thousand USD | -7.29% |
| 2000 FY | 362.9 Thousand USD | -24.2% |
| 1999 FY | 478.73 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aion Therapeutic Inc. | 210.67 Thousand CAD | -644725.606% |
| Ayurcann Holdings Corp. | 14.85 Million CAD | -9045.536% |
| Blueberries Medical Corp. | 2.41 Million CAD | -56112.49% |
| The BC Bud Corporation | 632.06 Thousand CAD | -214824.865% |
| BioNxt Solutions Inc. | 1.26 Million CAD | -107072.064% |
| CordovaCann Corp. | 10.26 Million CAD | -13135.638% |
| Christina Lake Cannabis Corp. | 15.96 Million CAD | -8410.356% |
| Captor Capital Corp. | 33.85 Million CAD | -3912.666% |
| City View Green Holdings Inc. | 3846.00 CAD | -35321454.862% |
| 1CM Inc. | 34.01 Million CAD | -3893.287% |
| Global Hemp Group Inc. | 42.76 Thousand CAD | -3176783.141% |
| Greenway Greenhouse Cannabis Corporation | 33.08 Million CAD | -4005.479% |
| IM Cannabis Corp. | 48.81 Million CAD | -2683.002% |
| Lobe Sciences Ltd. | 2.29 Million CAD | -58976.857% |
| Maple Leaf Green World Inc. | 168.27 Thousand CAD | -807199.448% |
| Mountain Valley MD Holdings Inc. | 8.96 Million CAD | -15051.316% |
| Nextleaf Solutions Ltd. | 8.53 Million CAD | -15812.632% |
| Ovation Science Inc. | 76.88 Thousand CAD | -1766712.767% |
| Pharmadrug Inc. | 1.45 Million CAD | -92965.7% |
| Captiva Verde Wellness Corp. | 9.1 Million CAD | -14824.44% |
| RAMM Pharma Corp. | 32.3 Million CAD | -4105.729% |
| RIV Capital Inc. | 1.74 Million CAD | -77948.056% |
| Revive Therapeutics Ltd. | 10.63 Million CAD | -12672.459% |
| Red White & Bloom Brands Inc. | 234.25 Million CAD | -479.914% |
| SLANG Worldwide Inc. | 33.2 Million CAD | -3991.391% |
| 1933 Industries Inc. | 18.01 Million CAD | -7438.776% |
| Red Light Holland Corp. | 24.08 Million CAD | -5540.547% |
| Top Strike Resources Corp. | 11.73 Million CAD | -11475.996% |
| Xebra Brands Ltd. | 379.36 Thousand CAD | -357986.871% |
| Adastra Holdings Ltd. | 32.34 Million CAD | -4100.218% |